Yu Ning Lin

GI & Metabolic Bariatric Surgeon Chang Gung Memorial Hospital trained @TaipeiMedicalU Love photography, hiking and traveling. Have a border collie

[Dr. Johnny Stewart. MD , FRCSC / RMC, CAF @DrJonnys]

Never trust the bile duct, "because the unusual is the usual"
#SoMe4IQLatAm #SoMe4Surgery #MedTwitter #Liver #GITwitter

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

New—Time for personalised #incretin titration https://t.co/NqaS6j3L8s
#FREE to read

[EASO @EASOobesity]

Algorithm 2.0: EASO Pharmacological Framework for Obesity Management

✔️ Helps clinicians match pharmacological obesity management to an individual’s health needs, moving beyond weight loss alone to consider complications, mechanisms & treatment goals.

https://t.co/289FP5r93D

[Annals of Hepato-Biliary-Pancreatic Surgery @Journal_AHBPS]

Resect first in resectable colorectal liver metastases: Recalibrating the default
🌷https://t.co/ZvM4Zl2JXZ
Ann Hepatobiliary Pancreat Surg 2026;30(3). Rathin Gosavi
#ColorectalNeoplasms #NeoplasmMetastasis #NeoadjuvantTherapy #Hepatectomy #AblationTechniques

[General Surgery News @gensurgnews]

What happens 10 years after hernia repair?
A new perspective calls for longer follow-up, standardized recurrence grading and a shift toward viewing ventral hernia as a chronic disease: https://t.co/TW28dUxexf #hernia #surgery

[AmJSurgery @AmJSurgery]

The Rise of Coaching in Surgery: Promise, Limits, and the Need for Systemic Change 🔪 @herbchen @pferrada1 @PipeCabreraV @CiruAndes2 @SWexner @TomVargheseJr @sminaev2015 Link: https://t.co/2EdNlpDMRY

[Japan Society for Endoscopic Surgery (JSES) @jses_eng]

🏆Grand Prize
We are pleased to announce that this entry has been selected as the Grand Prize winner of the 2nd Endoscopic Surgery Illustration Contest.
Congratulations!
#JSES
@IFSES_WCES @SAGES_Updates @EAES_eu @ELSA_surgeons

[Annals of Surgery @AnnalsofSurgery]

During implementation of robot-assisted pancreatoduodenectomy in a high-volume center, increasing experience was associated with shorter operative time, fewer complications, shorter hospital stay, and hospital costs comparable to open surgery. https://t.co/K5mzIn9Bym

[General Surgery News @gensurgnews]

🩺 Hernia repair isn’t always routine.
New insights from #ACSCC25 explore how judgment, technique, and patient-specific strategy shape outcomes in complex hernia care: https://t.co/gGRKW7Ptux #surgery #hernia

[Jan Král @KralJan]

🩸 Peptic ulcer bleeding, updated for 2026:

✅ ESGE keeps early endoscopy ≤24 h ⏱️ after resuscitation 💧 and expands endoscopic options 🔬including OTS clips for high-risk ulcers.

📚https://t.co/dMdXwo5jpI

#GITwitter #Endoscopy #MedEd #MedTwitter @ESGE_news @ASGEendoscopy

[Mariam Naveed, MD, FACG @MN_GIMD]

One of the most important questions in “refractory GERD”:

Is it actually GERD?

Excellent pearls from @kia_leila on the pseudo-GERD trap:

🔹 Reflux hypersensitivity ≠ functional heartburn
🔹 Rumination can often be diagnosed from the history
🔹 Postprandial HRIM can confirm the physiology
🔹 Treatment may be behavioral—not another escalation of acid suppression

Phenotype first. Treat the mechanism.

#Foregut2026 #GITwitter #GERD

[Dr. Nikhil Agrawal @drnkhl]

Gallbladder polyp management isn’t just size-based. European vs SRU guidelines differ on size, morphology, risk & follow-up. Some polyps may be malignant, surgical planning matters.
Do you use European, SRU, or individualized approach?
When consider extended cholecystectomy?

[Endoscopy Journal @endoscopyjrnl]

Editor’s Choice: Endoscopic diagnosis and management of peptic ulcer bleeding: ESGE Guideline – Update 2026

Find the article at: https://t.co/QbwPJsbyx0

Ian M. Gralnek et al.
@ESGE_news

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Obesity treatment is expected to shift gradually from a one-size-fits-all approach towards more personalised medicine, in which the obesity phenotype and presence of related conditions will determine the treatment strategy https://t.co/IFPyEU8bKn
#obesity #GLP-1 receptor agonists

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with #overweight or #obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial https://t.co/BtnwWNr0KX
#STEP 12

[JAMA Surgery @JAMASurgery]

Preoperative #GLP1 receptor agonist use was not associated with greater 12-month weight loss after #BariatricSurgery, and postoperative outcomes were similar to those of patients not taking these medications.

https://t.co/wh7lV95Rgk

[Bruno Ramos-Molina, PhD @Brunorm84]

Bariatric surgery resolves #MASH by enhancing MAT1A-dependent one-carbon metabolism @NatureComms https://t.co/Y28p8KteCF

[Japan Society for Endoscopic Surgery (JSES) @jses_eng]

🎨 2nd JSES Illust Contest #9
📌 Four-stitch suturing technique for robotic pancreaticojejunostomy
🖊 Takaki Furuyama
#JSESイラストコンテスト #JSES_illustration_contest

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

New—Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with #overweight or #obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial https://t.co/BtnwWNr0KX
#STEP 12

[JAMA @JAMA_current]

💬 Editorial by JAMA Executive Managing Editor Annette Flanagin, RN, MA, @JAMAplusAI Editor in Chief, Roy Perlis, MD, MSc, JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS:

Updated JAMA Network guidance on use of #AI in medical publication permits some uses by authors with disclosure, including manuscript preparation, translation, literature search, and research reporting, while reaffirming that authors are responsible for the accuracy and integrity of all submitted content.

The guidance does not permit use of #AI to draft Opinion manuscripts, Letters to the Editor, or online Comments.

🔗 Read the editorial: https://t.co/ouKcQpXZo2